It had been long awaited on the Frankfurt stock market and it had been apparent for weeks that it would be successful: the IPO of the German prosthesis manufacturer Ottobock. As early as September, it was leaked from banking circles that the securities of the more than hundred-year-old company were selling like hotcakes. Ultimately, the issue was several times oversubscribed, and there were twelve buy orders for each share offered. What could possibly go wrong?
